Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi/Genzyme: The Hard Work Begins
InVivo
Thursday, February 17, 2011 - 1:44pm
tags:
Sanofi, Genzyme, M&A
Earnings Scorecard: Life Technologies
Yahoo/Zacks.com
Thursday, February 17, 2011 - 1:19pm
tags:
earnings, Life Technologies
Sales reps say medical knowledge, business acumen are keys to access
Medical Marketing & Media
Thursday, February 17, 2011 - 1:07pm
tags:
drug reps
Nurse Practitioners Like Pharma Lunches & Dinners
Pharmalot
Thursday, February 17, 2011 - 1:05pm
tags:
nurse practitioners, drug reps
Endo Pharma Starts Cancer Trial
Yahoo/Zacks.com
Thursday, February 17, 2011 - 1:04pm
tags:
Endo, Bioniche Pharma, Urocidin, Spectrum Pharmaceuticals
Inspire beats Street with 4Q, 2010 earnings, revenue
Bizjournals.com
Thursday, February 17, 2011 - 1:03pm
tags:
Inspire, earnings
Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
Seeking Alpha
Thursday, February 17, 2011 - 1:02pm
tags:
Apricus Biosciences, liver cancer, ProvOnco, Threshold Pharmaceuticals
Biotechs Ready To Roll
Investopedia
Thursday, February 17, 2011 - 9:36am
tags:
Aeterna Zentaris, Jazz Pharmaceuticals, ONYX Pharmaceuticals, Spectrum Pharmaceuticals
Generic Drugs have Market Vulnerabilities Too
Pharmareform
Thursday, February 17, 2011 - 9:31am
tags:
generics
FDA’s Longer Drug, Device Exams Hinder Innovation, Study Finds
Bloomberg
Thursday, February 17, 2011 - 9:30am
tags:
FDA, innovation
Louisiana Attorney General Sues Glaxo Over Avandia
Pharmalot
Thursday, February 17, 2011 - 9:03am
tags:
Avandia, GSK, lawsuits, diabetes
AstraZeneca Said to Pay $150 Million to Settle Seroquel Suits
Bloomberg
Thursday, February 17, 2011 - 9:02am
tags:
settlements, AstraZeneca, Seroquel
Aveo Pharma, Astellas in $1.3B cancer drug deal
Yahoo/AP
Thursday, February 17, 2011 - 9:01am
tags:
Aveo Pharmaceutical, Astellas, cancer, tivozanib, Pfizer, ONYX Pharmaceuticals
Amgen Falls On Medicare Worries
Forbes
Thursday, February 17, 2011 - 7:59am
tags:
Medicare, Amgen, Aranesp, Epogen, anemia
Sanofi-Genzyme: What the Analysts Are Saying
Seeking Alpha
Thursday, February 17, 2011 - 7:58am
tags:
analysts, M&A, Sanofi, Genzyme
What Are Big Investors Doing With Pfizer?
Seeking Alpha
Thursday, February 17, 2011 - 7:57am
tags:
Pfizer
Pipeline at Alkermes Advances
Yahoo/Zacks.com
Thursday, February 17, 2011 - 7:56am
tags:
Alkermes, Amylin, JNJ, ALKS 37, opiod-induced constipation
This Pharma-Biotech Marriage May Need to Pay Off Right Away
WSJ Online
Thursday, February 17, 2011 - 7:55am
tags:
Sanofi, M&A, Genzyme
FDA Likely to Approve Spectrum Pharma's Cancer Drug After Second Look
Seeking Alpha
Wednesday, February 16, 2011 - 11:27am
tags:
FDA, Fusilev, Spectrum Pharmaceuticals, Teva Pharmaceuticals, colorectal cancer
United Therapeutics Swings to Profit in Q4
Seeking Alpha
Wednesday, February 16, 2011 - 11:26am
tags:
earnings, United Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.